We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$8.02B
AUM Growth
+$201M
Cap. Flow
-$89M
Cap. Flow %
-1.11%
Top 10 Hldgs %
19.81%
Holding
867
New
76
Increased
308
Reduced
302
Closed
63

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$48.8M
2
PG icon
Procter & Gamble
PG
+$24.6M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$23.6M
4
KEYS icon
Keysight
KEYS
+$23.2M
5
BMY icon
Bristol-Myers Squibb
BMY
+$21.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$46.5M
2
XOM icon
ExxonMobil
XOM
+$36.6M
3
GG
Goldcorp Inc
GG
+$24.9M
4
DIS icon
Walt Disney
DIS
+$23.8M
5
NAVG
Navigators Group Inc
NAVG
+$19.1M

Sector Composition

Rank Sector Weight
1 Healthcare 33.16%
2 Technology 16.87%
3 Financials 10.38%
4 Consumer Discretionary 9.09%
5 Communication Services 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLK icon
326
Blackrock
BLK
$164B
$4.81M 0.06%
10,292
+77
+0.8% +$34.8K
FANG icon
327
Diamondback Energy
FANG
$57.6B
$4.8M 0.06%
44,242
-49,620
-53% -$5.18M
AVB icon
328
AvalonBay Communities
AVB
$27.1B
$4.8M 0.06%
14,683
+3,080
+27% +$624K
TM icon
329
Toyota
TM
$210B
$4.71M 0.06%
38
– –
NATI
330
DELISTED
National Instruments Corp
NATI
$4.67M 0.06%
111,836
-28,940
-21% -$1.23M
GM icon
331
General Motors
GM
$74.7B
$4.62M 0.06%
120,427
-1,490
-1% -$55.9K
ZTS icon
332
Zoetis
ZTS
$31.6B
$4.62M 0.06%
40,876
-1,337
-3% -$140K
AQ
333
DELISTED
Aquantia Corp. Common Stock
AQ
$4.61M 0.06%
+355,454
New +$4.15M
K
334
DELISTED
Kellanova
K
$4.61M 0.06%
92,025
-4,186
-4% -$222K
PSX icon
335
Phillips 66
PSX
$82.9B
$4.6M 0.06%
49,364
-10,186
-17% -$914K
NFG icon
336
National Fuel Gas
NFG
$7.84B
$4.59M 0.06%
87,316
+20,695
+31% +$1.18M
CHD icon
337
Church & Dwight Co
CHD
$23.1B
$4.58M 0.06%
62,918
+11,376
+22% +$846K
PH icon
338
Parker-Hannifin
PH
$125B
$4.55M 0.06%
26,884
+5,307
+25% +$915K
TBPH icon
339
Theravance Biopharma
TBPH
$874M
$4.55M 0.06%
279,700
– –
KEY icon
340
KeyCorp
KEY
$24.3B
$4.52M 0.06%
255,893
-8,615
-3% -$146K
CPRI icon
341
Capri Holdings
CPRI
$1.77B
$4.52M 0.06%
130,939
+52,307
+67% +$2.13M
CMI icon
342
Cummins
CMI
$91.7B
$4.51M 0.06%
26,434
-7,229
-21% -$1.18M
EW icon
343
Edwards Lifesciences
EW
$47.6B
$4.49M 0.06%
73,287
+2,478
+3% +$150K
BSX icon
344
Boston Scientific
BSX
$65.8B
$4.46M 0.06%
104,242
-5,851
-5% -$225K
SGMO
345
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$4.45M 0.06%
+415,000
New +$4.41M
WRK
346
DELISTED
WestRock Company
WRK
$4.38M 0.05%
120,762
-1,210
-1% -$44.5K
CXO
347
DELISTED
CONCHO RESOURCES INC.
CXO
$4.36M 0.05%
42,433
-891
-2% -$96.1K
MRO
348
DELISTED
Marathon Oil Corporation
MRO
$4.33M 0.05%
306,259
-286,877
-48% -$4.44M
IPG
349
DELISTED
Interpublic Group of Companies
IPG
$4.33M 0.05%
192,517
-238,714
-55% -$5.3M
MDGL icon
350
Madrigal Pharmaceuticals
MDGL
$12.6B
$4.33M 0.05%
41,450
– –
12 13
14
15 16

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2019 Portfolio in Review

As of Q2 2019, Candriam SCA held 867 positions worth $8.02B, up 2.6% from $7.82B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA's Q2 2019 filing shows 76 new, 308 increased, 302 reduced and 63 closed positions. Its largest new stake was Total System Services, Inc.: 112,342 shares worth $14.3M. The largest sale was Celgene Corp, an estimated $46.5M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q2 2019 buy was Total System Services, Inc.: 112,342 shares worth $14.3M.
  • Candriam SCA added most to Vertex Pharmaceuticals in Q2 2019, an estimated $48.8M increase.
  • Candriam SCA's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $46.5M.
  • Candriam SCA fully exited Goldcorp Inc in Q2 2019, selling an estimated $24.9M.
  • Candriam SCA's ten largest holdings make up 20% of its $8.02B portfolio in Q2 2019.
  • Candriam SCA opened 76 new positions and closed 63 in Q2 2019.
  • Candriam SCA's portfolio value rose 2.6% quarter-over-quarter to $8.02B.

Based on Candriam SCA's 13F filing for Q2 2019, filed 1 Aug 2019.